Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel “first-in-class” anti-inflammatory drug candidates: a reviewer’s perspective

G. Mathew, M.K. Unnikrishnan

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)747-752
Number of pages6
JournalInflammation Research
Volume64
Issue number10
DOIs
Publication statusPublished - 2015
Externally publishedYes

Cite this

@article{146b8beb07ed44f294f662602f3d52ab,
title = "Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel “first-in-class” anti-inflammatory drug candidates: a reviewer’s perspective",
author = "G. Mathew and M.K. Unnikrishnan",
note = "cited By 1",
year = "2015",
doi = "10.1007/s00011-015-0851-8",
language = "Undefined/Unknown",
volume = "64",
pages = "747--752",
journal = "Inflammation Research",
issn = "1023-3830",
publisher = "Birkh{\"a}user-Verlag",
number = "10",

}

TY - JOUR

T1 - Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel “first-in-class” anti-inflammatory drug candidates: a reviewer’s perspective

AU - Mathew, G.

AU - Unnikrishnan, M.K.

N1 - cited By 1

PY - 2015

Y1 - 2015

U2 - 10.1007/s00011-015-0851-8

DO - 10.1007/s00011-015-0851-8

M3 - Article

VL - 64

SP - 747

EP - 752

JO - Inflammation Research

JF - Inflammation Research

SN - 1023-3830

IS - 10

ER -